SEK 0.32
(6.6%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | -4.92 Million SEK | 0.0% |
2022 | - SEK | 0.0% |
2021 | - SEK | 0.0% |
2020 | - SEK | 100.0% |
2019 | -1472.17 SEK | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - SEK | 0.0% |
2024 Q1 | - SEK | 100.0% |
2023 Q4 | -4.92 Million SEK | -97004.02% |
2023 FY | -4.92 Million SEK | 0.0% |
2023 Q3 | -5076.00 SEK | 30.07% |
2023 Q2 | -7259.00 SEK | 15.56% |
2023 Q1 | -8597.00 SEK | 0.0% |
2022 Q2 | - SEK | 0.0% |
2022 Q1 | - SEK | 0.0% |
2022 FY | - SEK | 0.0% |
2022 Q4 | - SEK | 100.0% |
2022 Q3 | -3.47 Million SEK | 0.0% |
2021 Q2 | -1.93 Million SEK | 0.0% |
2021 Q4 | - SEK | 100.0% |
2021 Q3 | -3.4 Million SEK | -75.93% |
2021 FY | - SEK | 0.0% |
2021 Q1 | - SEK | 0.0% |
2020 FY | - SEK | 100.0% |
2019 FY | -1472.17 SEK | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Active Biotech AB (publ) | -2500.00 SEK | -197060.0% |
Biovica International AB (publ) | 2.19 Million SEK | 324.147% |
Cantargia AB (publ) | - SEK | Infinity% |
CombiGene AB (publ) | -1.79 Million SEK | -173.986% |
Cyxone AB (publ) | - SEK | Infinity% |
Diagonal Bio AB (publ) | 1.02 Million SEK | 579.475% |
Elicera Therapeutics AB (publ) | -446.98 Thousand SEK | -1002.719% |
ExpreS2ion Biotech Holding AB (publ) | - SEK | Infinity% |
Fluicell AB (publ) | 3.15 Million SEK | 256.476% |
Infant Bacterial Therapeutics AB (publ) | - SEK | Infinity% |
Mendus AB (publ) | - SEK | Infinity% |
Isofol Medical AB (publ) | - SEK | Infinity% |
I-Tech AB | 4.28 Million SEK | 215.164% |
Intervacc AB (publ) | 10.48 Million SEK | 147.019% |
Lipigon Pharmaceuticals AB (publ) | -1.62 Million SEK | -203.137% |
Magle Chemoswed Holding AB (publ) | 35.22 Million SEK | 113.991% |
Modus Therapeutics Holding AB (publ) | - SEK | Infinity% |
OncoZenge AB (publ) | -862.99 Thousand SEK | -471.148% |
Sprint Bioscience AB (publ) | -7.13 Million SEK | 30.928% |
Xbrane Biopharma AB (publ) | 106.85 Million SEK | 104.613% |
Lipum AB (publ) | - SEK | Infinity% |
Alligator Bioscience AB (publ) | 2.00 SEK | 246450100.0% |
Ziccum AB (publ) | -4.18 Million SEK | -17.665% |
BioArctic AB (publ) | - SEK | Infinity% |
Genovis AB (publ.) | 14.9 Million SEK | 133.069% |
Camurus AB (publ) | 100.95 Million SEK | 104.882% |
IRLAB Therapeutics AB (publ) | 1000.00 SEK | 493000.0% |
Bio-Works Technologies AB (publ) | 9.06 Million SEK | 154.356% |
Aptahem AB (publ) | - SEK | Infinity% |
Vicore Pharma Holding AB (publ) | - SEK | Infinity% |
Xspray Pharma AB (publ) | 43.78 Million SEK | 111.258% |
Kancera AB (publ) | -1950.00 SEK | -252669.231% |
Saniona AB (publ) | 1.00 SEK | 492900100.0% |
Spago Nanomedical AB (publ) | 1.00 SEK | 492900100.0% |
AcouSort AB (publ) | 2.08 Million SEK | 336.971% |
Xintela AB (publ) | 398 Thousand SEK | 1338.442% |
Abliva AB (publ) | - SEK | Infinity% |
Karolinska Development AB (publ) | - SEK | Infinity% |
Amniotics AB (publ) | 534 Thousand SEK | 1023.034% |
2cureX AB (publ) | -1000.00 SEK | -492800.0% |
Asarina Pharma AB (publ) | - SEK | Infinity% |
Calliditas Therapeutics AB (publ) | 20.42 Million SEK | 124.129% |
Hansa Biopharma AB (publ) | 9.79 Million SEK | 150.337% |
QuiaPEG Pharmaceuticals Holding AB (publ) | - SEK | Infinity% |
Corline Biomedical AB | -3.85 Million SEK | -27.794% |
NextCell Pharma AB | 545.23 Thousand SEK | 1004.011% |
Nanologica AB (publ) | 2.97 Million SEK | 265.792% |
LIDDS AB (publ) | - SEK | Infinity% |
Egetis Therapeutics AB (publ) | 700 Thousand SEK | 804.143% |
BioInvent International AB (publ) | 11.84 Million SEK | 141.616% |
SynAct Pharma AB | - SEK | Infinity% |
Annexin Pharmaceuticals AB (publ) | - SEK | Infinity% |
Stayble Therapeutics AB (publ) | -321.14 Thousand SEK | -1434.821% |
Alzinova AB (publ) | -3.27 Million SEK | -50.366% |
Ascelia Pharma AB (publ) | - SEK | Infinity% |
Oncopeptides AB (publ) | 2.42 Million SEK | 303.258% |
Pila Pharma AB (publ) | 1.00 SEK | 492900100.0% |
Guard Therapeutics International AB (publ) | -1486.00 SEK | -331595.828% |
Scandinavian ChemoTech AB (publ) | 4.03 Million SEK | 222.186% |
Simris Alg AB (publ) | 1.09 Million SEK | 551.787% |
Diamyd Medical AB (publ) | 24.05 Million SEK | 120.495% |